Cargando…

Oral health status of a population with multiple sclerosis

Objective: To determine the oral treatment needs of a sample of patients diagnosed with multiple sclerosis in the Community of Madrid (Spain). Patients and methods: A cross-sectional epidemiological study was carried out with a sample of 64 patients who were aged 25 to 77 years. They were distribute...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santa Eulalia-Troisfontaines, Eva, Martínez-Pérez, Eva M., Miegimolle-Herrero, Mónica, Planells-del-Pozo, Paloma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medicina Oral S.L. 2012
Materias:	Research-Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3448308/ https://www.ncbi.nlm.nih.gov/pubmed/22143682 http://dx.doi.org/10.4317/medoral.17340

Ejemplares similares

Importance of Desensitization for Autistic Children in Dental Practice
por: Martínez Pérez, Eva, et al.
Publicado: (2023)

Oral health status of 6- to 12-year-old children in Madrid, Spain: A cross-sectional study
por: Adanero, Alberto, et al.
Publicado: (2022)

Cognitive status in patients with multiple sclerosis in Lanzarote
por: Pérez-Martín, María Yaiza, et al.
Publicado: (2016)

Microbiology of molar–incisor hypomineralization lesions. A pilot study
por: Hernández, Miguel, et al.
Publicado: (2020)

A 3D Model of the Jaw Applied to Paediatric Dentistry
por: Legorburu, Begoña Gómez, et al.
Publicado: (2022)

The Status of Multiple Sclerosis
por: Glaser, Gilbert H.
Publicado: (1955)

A New Approach to Diagnosis to Posterior Cross Bite: Intraoral Photography and Wala Ridge
por: Ramón, Rocío, et al.
Publicado: (2022)

Oral Health Status and Multiple Sclerosis: Classic and Non-Classic Manifestations—Case Report
por: Costa, Céu, et al.
Publicado: (2022)

Expression Pattern of Myelin-Related Apolipoprotein D in Human Multiple Sclerosis Lesions
por: Navarro, Ana, et al.
Publicado: (2018)

La choix de J.-P. Sartre : exposé et critique de L'{circ}etre et le néant /
por: Troisfontaines, Roger
Publicado: (1945)

De l'existence a l'etre : la philosophie de Gabriel Marcel /
por: Troisfontaines, Roger
Publicado: (1953)

Real‐world experience of ocrelizumab in multiple sclerosis in a Spanish population
por: Fernandez‐Diaz, Eva, et al.
Publicado: (2020)

Epigenetic signatures of invasive status in populations of marine invertebrates
por: Ardura, Alba, et al.
Publicado: (2017)

The Broad Concept of “Spasticity-Plus Syndrome” in Multiple Sclerosis: A Possible New Concept in the Management of Multiple Sclerosis Symptoms
por: Fernández, Óscar, et al.
Publicado: (2020)

Monitoring the Redox Status in Multiple Sclerosis
por: Tanaka, Masaru, et al.
Publicado: (2020)

PRKCA and Multiple Sclerosis: Association in Two Independent Populations
por: Saarela, Janna, et al.
Publicado: (2006)

Baseline Inflammatory Status Reveals Dichotomic Immune Mechanisms Involved In Primary-Progressive Multiple Sclerosis Pathology
por: Fernández-Velasco, José I., et al.
Publicado: (2022)

COVID-19 Vaccine Status, Intent, Hesitancy, and Disease-Related Beliefs in People with Multiple Sclerosis
por: Grech, Lisa, et al.
Publicado: (2023)

Multiple Sclerosis and Microbiome
por: Preiningerova, Jana Lizrova, et al.
Publicado: (2022)

Fear, fight, familiarize: the experiences of people living with relapsing-remitting multiple sclerosis and taking oral medication
por: Van Reenen, Eva, et al.
Publicado: (2019)

Recommendations for the Diagnosis and Treatment of Multiple Sclerosis Relapses
por: Ramo-Tello, Cristina, et al.
Publicado: (2021)

Oral Disease-Modifying Therapies for Multiple Sclerosis
por: Kim, Woojun, et al.
Publicado: (2015)

Role of oral teriflunomide in the management of multiple sclerosis
por: Tanasescu, Radu, et al.
Publicado: (2013)

Hospitalization Rates and Discharge Status in Multiple Sclerosis
por: Nusrat, Sanober, et al.
Publicado: (2013)

Status migrainosus as an initial presentation of multiple sclerosis
por: Alroughani, Raed, et al.
Publicado: (2015)

Oral health status of patients with multiple myeloma
por: Feitosa, Édila Figuerêdo, et al.
Publicado: (2020)

Anti-CD20 therapies for multiple sclerosis: current status and future perspectives
por: Margoni, Monica, et al.
Publicado: (2021)

Transient but recurrent complete heart block in a patient after COVID-19 vaccination – A case report
por: Etienne, Hoffer, et al.
Publicado: (2022)

Oral-Health-Related Quality of Life as Measured with the Child-OIDP Index and Oral Health Status in Spanish Adolescents
por: Alvarez-Azaustre, María Paloma, et al.
Publicado: (2022)

Health Disparities in Multiple Sclerosis among Hispanic and Black Populations in the United States
por: Moore, Michael Z., et al.
Publicado: (2023)

Current Status of Oral Disease-Modifying Treatment Effects on Cognitive Outcomes in Multiple Sclerosis: A Scoping Review
por: Carlomagno, Vincenzo, et al.
Publicado: (2023)

Structural MRI correlates of PASAT performance in multiple sclerosis
por: Matias-Guiu, Jordi A., et al.
Publicado: (2018)

Enhancing diversity of clinical trial populations in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2023)

The Effect of Combining Transcranial Direct Current Stimulation Treatment and an Exercise Program on Fragility in a Population with Multiple Sclerosis: Cross-Over Design Trial
por: Muñoz-Paredes, Inés, et al.
Publicado: (2022)

New oral disease-modifying therapies for multiple sclerosis
por: Bagert, Bridget A, et al.
Publicado: (2009)

Development of oral immunomodulatory agents in the management of multiple sclerosis
por: Nicholas, Richard, et al.
Publicado: (2011)

Oral contraceptives combined with interferon β in multiple sclerosis
por: Pozzilli, Carlo, et al.
Publicado: (2015)

Assessment of safety and effectiveness of oral multiple sclerosis medication
por: Al Turaiki, Abdulrahman M., et al.
Publicado: (2019)

Bacterial variation in the oral microbiota in multiple sclerosis patients
por: Zangeneh, Zahra, et al.
Publicado: (2021)

The potential of serum neurofilament as biomarker for multiple sclerosis
por: Bittner, Stefan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5j4e9mhpc1622mg804m4i1bcjm